Cite Filings / CPIX / 0001628280-17-002720

Feed Companies Filings Check

Sign in

DEFR14A

Filing

CUMBERLAND PHARMACEUTICALS INC Filed 2017-03-20 Acc 0001628280-17-002720

Documents 1

DEFR14A , def-r2017proxystatement.htm

Around this filing

2017-03-24 4 Chief Financial Officer bought 900 shares at $6.42 ($5,778)
2017-03-24 4 Director bought 15,000 shares at $6.53 ($97,950)
2017-03-22 8-K/A Auditor change
2017-03-20 DEFR14A DEFR14A
2017-03-16 DEF 14A Proxy Statement
2017-03-16 DEFA14A Proxy Materials
2017-03-16 8-K Auditor change

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading def-r2017proxystatement.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…